Adagene (ADAG) Competitor Comparison
We are evaluating the key criteria listed to compare Adagene (ADAG) against its competitors in the Biotechnology industry.
Market Capitalization
242 / 368Gross Profits
0 / 278Total Revenue
157 / 300EBITDA
128 / 337Free Cashflow
0 / 352Quick Ratio
250 / 357Earnings per Share
93 / 359Dividend yield
0 / 6Total Cash
198 / 358Performance 3 years
227 / 368Performance 5 years
268 / 368Performance 10 years
233 / 368Linearity 3 years
235 / 368Linearity 5 years
300 / 368Linearity 10 years
281 / 368Total Rank
113 / 368Dividend Rank
329 / 368Valuation Rank
146 / 368Piotroski Rank
252 / 368Muliplier Rank
252 / 368Gross Profits - ADAG ranking 0 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.